Diamyd starts larger trial in type 2 diabetes patients in Sweden
October 07, 2004 08:21 ET
|
Diamyd Medical
STOCKHOLM, Sweden, Oct. 7, 2004 (PRIMEZONE) -- At the International Diabetes Federation meeting in Los Angeles, USA, it will be announced today that a larger clinical trial with Diamyd will start in...
20MUSD to Diamyd Medical through new stock emission
June 14, 2004 11:15 ET
|
Diamyd Medical
STOCKHOLM, Sweden, June 14, 2004 (PRIMEZONE) -- Diamyd Medical's preferential rights issue in May of up to 2 318 189 B- shares has been oversubscribed by 70%. The Board has therefore decided, in...
Diabetes Therapeutic Diamyd is effective for at least 2 years
June 10, 2004 10:51 ET
|
Diamyd Medical
STOCKHOLM, Sweden, June 10, 2004 (PRIMEZONE) -- 24-month data from Diamyd Medicals (TM) Phase II clinical trial with the diabetes therapeutic Diamyd(TM) were presented today at the American Diabetes...
Diamyd reports increased long-term effect in diabetes pharmaceutical and carries out guaranteed new share issue
April 05, 2004 05:05 ET
|
Diamyd Medical
STOCKHOLM, Sweden, April 05, 2004 (PRIMEZONE) --* 18-month data from the Phase II studies with Diamyd(TM) for the treatment of autoimmune diabetes shows that the positive effects achieved after six...
Diamyd, Inc., and Diarect AG Settles Dispute
December 08, 2003 02:35 ET
|
Diamyd Medical
STOCKHOLM, Sweden, Dec. 08, 2003 (PRIMEZONE) -- In a press release of November 27, Diamyd Medical wrote that it "won" a dispute over Diarect, and that the judge had "decided" in favor of Diamyd. As...
Diamyd, Inc. wins dispute with Diarect AG
November 27, 2003 04:41 ET
|
Diamyd Medical
STOCKHOLM, Sweden, Nov. 27, 2003 (PRIMEZONE) -- Diamyd Medical AB (listed on the Swedish Stock Exchange, O-list) develops a treatment for insulin dependent diabetes, Diamyd(TM). There has been an...
Diamyd increases C-peptide levels in diabetes patients with GAD antibodies
November 24, 2003 08:14 ET
|
Diamyd Medical
STOCKHOLM, Sweden, Nov. 24, 2003 (PRIMEZONE) -- Diamyd Medical (O-list) is developing the Diamyd(TM) pharmaceutical for insulin dependent diabetes. In the Annual Report for the financial year 02/03,...
Diamyd Medical: GAD2 Gene Therapy Might be used for Treatment of Anorexia
November 04, 2003 10:52 ET
|
Diamyd Medical
STOCKHOLM, Sweden, Nov. 4, 2003 (PRIMEZONE) -- An international research group, including among other authors Professor Philippe Froguel (Pasteur Institute, Lille, France) and Professor Ake Lernmark...
Parkinson patient treated with GAD gene therapy in New York
August 22, 2003 09:50 ET
|
Diamyd Medical
STOCKHOLM, Sweden, August 22, 2003 (PRIMEZONE) -- Diamyd Medical (O-list) informs that Neurologix Inc has treated a first patient suffering from Parkinson's disease using GAD gene therapy. Diamyd...
Diamyd reports successful clinical phase II trial with diabetes vaccine
June 14, 2003 11:07 ET
|
Diamyd Medical
STOCKHOLM, Sweden, June 14, 2003 (PRIMEZONE) -- Diamyd Medical AB, publicly traded on the Stockholm Stock Exchange in Sweden (O-list), today reported a positive outcome from a phase II trial with its...